Vimarsana
Biggest News Aggregation in the World

Page 31 - Group Information News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Group Information. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Group Information Today - Breaking & Trending Today

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis - Vimarsana News

Paclitaxel-Coated Balloon vs Uncoated Balloon for Coronary In-Stent Restenosis

This clinical trial compares a paclitaxel-coated balloon vs an uncoated balloon in patients with in-stent restenosis undergoing percutaneous coronary interventi

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial | Critical Care Medicine | JAMA - Vimarsana News

Neurodevelopmental Outcomes of Extremely Preterm Infants Fed Donor Milk or Preterm Infant Formula: A Randomized Clinical Trial | Critical Care Medicine | JAMA

This randomized clinical trial compares the effect of donor human milk on neurodevelopmental outcomes at 22 to 26 months’ corrected age compared with preterm in

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial | Anticoagulation | JAMA - Vimarsana News

Effect of Intermediate-Dose vs Standard-Dose Prophylactic Anticoagulation on Thrombotic Events, Extracorporeal Membrane Oxygenation Treatment, or Mortality Among Patients With COVID-19 Admitted to the Intensive Care Unit: The INSPIRATION Randomized Clinical Trial | Anticoagulation | JAMA

This randomized trial compares the effect of intermediate-dose vs standard prophylactic enoxaparin on a composite outcome of acute venous thromboembolism (VTE),

RNA Interference With Zilebesiran for Mild to Moderate Hypertension - Vimarsana News

RNA Interference With Zilebesiran for Mild to Moderate Hypertension

This phase 2 randomized trial examines the antihypertensive efficacy and safety of different zilebesiran dosing regimens.

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke - Vimarsana News

Methylprednisolone as Adjunct to Endovascular Thrombectomy for Large-Vessel Occlusion Stroke

This clinical trial assesses the efficacy and adverse events of adjunctive intravenous low-dose methylprednisolone to endovascular thrombectomy for patients wit